Hypoxia is the situation that arises when the cellular demand for oxygen to produce sufficient amounts of ATP to maintain cellular function exceeds the supply. This situation can occur in a number of ways, including exposure to high altitude \[[@B1]\], increased metabolic activity, disruption of vascular supply \[[@B2]\], inflammation/injury \[[@B3]\], and tumorigenesis \[[@B4]\]. Over the course of evolution, organisms have developed the ability to adapt to conditions of hypoxia and elicit non-transcriptional and transcriptional responses in order to promote adaptation and survival. The alpha subunits of the hypoxia-inducible factor transcription factor family (HIF-1α and HIF-2α) have been identified as the master regulators of the cellular response to hypoxia \[[@B5],[@B6]\]. Together, these proteins regulate the expression of hundreds of genes involved in erythropoiesis, angiogenesis, vasodilation, glucose transport, glycolysis, iron metabolism, barrier function, and stem cell function in a multi-faceted adaptation to low oxygen.

HIF-1α and HIF-2α are encoded by different genes but share significant sequence homology. The relative contribution of each subunit to transcriptional regulation is not yet fully described, and they were initially thought to have largely overlapping functions. However, there is emerging evidence for these oxygen-regulated transcription factors to have specific, divergent, and even opposing functions, depending on the context \[[@B7]-[@B9]\]. The micro-environment in which stem cells reside is complex and is subject to gradients of oxygen. Indeed, oxygen levels have been reported to direct stem cell differentiation or quiescence in different cell types \[[@B7]\]. Thus, stem cells and tumor stem cells can reside within a hypoxic niche and are influenced by HIFs \[[@B8]\]. HIF-1α is described as having a dominant role in modulating WNT-β-catenin signaling, whereas HIF-2α regulates OCT4, a transcription factor involved in maintaining embryonic stem cells in an undierentiated state \[[@B9]\].

In a recent article in *Stem Cells*, Das and colleagues \[[@B10]\] investigate the regenerative potential of human embryonic stem cells (hESCs) with respect to HIF signaling. The central premise of this paper is that stem cells have the ability to contribute to cytoprotection of adjacent tissue through the secretion of protective growth factors and antioxidants. This \'altruistic\' behavior would be attractive to exploit in the context of regenerative medicine. To achieve this in the context of tissue injury, stem cells would need to be functionally undifferentiated during hypoxia and oxidative stress. Das and colleagues demonstrate that, following exposure to hypoxia/oxidative stress (to mimic a site of injury), a small fraction of stem cells (SSEA3^+^/ABCG2^+^) have the ability to adopt a low-p53 and high-HIF-2α state for up to two weeks. This phenotype is associated with enhanced activity of Oct-4 and Nanog and is dubbed by the authors an \'enhanced stemness\' (EnSt) phenotype. The EnSt phenotype is accompanied by a high degree of self-sufficiency as measured by *in vitro*clonogenic assays as well as *in vivo*teratoma assays. In each case, the self-sufficiency of the EnSt hESCs was comparable to that of a teratoma-derived cell (Tera-2). Furthermore, conditioned media from EnSt cells had significant cytoprotective effects comparable to those of antioxidant NAC (N-acetyl cysteine).

The role of the HIFs was investigated and the authors found that HIF-2α-mediated suppression of p53 is central to maintenance of the EnSt phenotype. Silencing of HIF-2α with siRNA (small interfering RNA) in the EnSt phenotype cells led to an almost fourfold increase in apoptosis relative to controls which was furthermore associated with a similar increase in p53 expression in the surviving cells. Thus, HIF-2α was reported to contribute to an abnormal p53/MDM2 (a negative regulator of p53) oscillation (with EnSt cells displaying high-HIF-2α, low-p53, and high-MDM2 expression). HIF-1α was induced by hypoxia in the model, but unlike HIF-2α expression, its expression declined markedly following reoxygenation.

For regenerative medicine, the key questions arising from the work of Das and colleagues \[[@B10]\] are whether adult stem cells could exhibit activity similar to that of the hESCs used in the study and whether an \'enhanced stemness\' phenotype could be therapeutically exploited at sites of injury in order to protect other cells from injury.
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